vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and BRANDYWINE REALTY TRUST (BDN). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $127.0M, roughly 1.5× BRANDYWINE REALTY TRUST). Axsome Therapeutics, Inc. runs the higher net margin — -14.6% vs -38.4%, a 23.9% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 4.5%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 0.7%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.
AXSM vs BDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $127.0M |
| Net Profit | $-28.6M | $-48.8M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | 1.2% |
| Net Margin | -14.6% | -38.4% |
| Revenue YoY | 65.0% | 4.5% |
| Net Profit YoY | 61.9% | -80.4% |
| EPS (diluted) | $-0.55 | $-0.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $127.0M | ||
| Q4 25 | $196.0M | $121.0M | ||
| Q3 25 | $171.0M | $121.4M | ||
| Q2 25 | $150.0M | $120.6M | ||
| Q1 25 | $121.5M | $121.5M | ||
| Q4 24 | $118.8M | $121.9M | ||
| Q3 24 | $104.8M | $131.8M | ||
| Q2 24 | $87.2M | $125.3M |
| Q1 26 | — | $-48.8M | ||
| Q4 25 | $-28.6M | $-36.7M | ||
| Q3 25 | $-47.2M | $-25.9M | ||
| Q2 25 | $-48.0M | $-88.7M | ||
| Q1 25 | $-59.4M | $-27.0M | ||
| Q4 24 | $-74.9M | $-44.5M | ||
| Q3 24 | $-64.6M | $-165.2M | ||
| Q2 24 | $-79.3M | $30.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 61.3% | ||
| Q3 25 | — | 62.6% | ||
| Q2 25 | — | 62.4% | ||
| Q1 25 | — | 60.8% | ||
| Q4 24 | — | 61.2% | ||
| Q3 24 | — | 64.9% | ||
| Q2 24 | — | 63.1% |
| Q1 26 | — | 1.2% | ||
| Q4 25 | -13.8% | 22.8% | ||
| Q3 25 | -27.0% | 20.8% | ||
| Q2 25 | -24.5% | -34.3% | ||
| Q1 25 | -46.9% | 12.5% | ||
| Q4 24 | -61.1% | 18.0% | ||
| Q3 24 | -59.8% | -7.2% | ||
| Q2 24 | -89.5% | 15.5% |
| Q1 26 | — | -38.4% | ||
| Q4 25 | -14.6% | -30.3% | ||
| Q3 25 | -27.6% | -21.3% | ||
| Q2 25 | -32.0% | -73.5% | ||
| Q1 25 | -48.9% | -22.2% | ||
| Q4 24 | -63.1% | -36.5% | ||
| Q3 24 | -61.7% | -125.4% | ||
| Q2 24 | -91.0% | 24.1% |
| Q1 26 | — | $-0.28 | ||
| Q4 25 | $-0.55 | $-0.21 | ||
| Q3 25 | $-0.94 | $-0.15 | ||
| Q2 25 | $-0.97 | $-0.51 | ||
| Q1 25 | $-1.22 | $-0.16 | ||
| Q4 24 | $-1.54 | $-0.25 | ||
| Q3 24 | $-1.34 | $-0.96 | ||
| Q2 24 | $-1.67 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $36.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | — |
| Total Assets | $689.8M | $3.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $36.2M | ||
| Q4 25 | $322.9M | $32.3M | ||
| Q3 25 | $325.3M | $75.5M | ||
| Q2 25 | $303.0M | $122.6M | ||
| Q1 25 | $300.9M | $29.4M | ||
| Q4 24 | $315.4M | $90.2M | ||
| Q3 24 | $327.3M | $36.5M | ||
| Q2 24 | $315.7M | $30.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | $2.3B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $2.2B |
| Q1 26 | — | — | ||
| Q4 25 | $88.3M | $792.7M | ||
| Q3 25 | $73.7M | $841.5M | ||
| Q2 25 | $73.1M | $879.8M | ||
| Q1 25 | $53.2M | $993.6M | ||
| Q4 24 | $57.0M | $1.0B | ||
| Q3 24 | $92.9M | $1.1B | ||
| Q2 24 | $102.9M | $1.3B |
| Q1 26 | — | $3.6B | ||
| Q4 25 | $689.8M | $3.6B | ||
| Q3 25 | $669.3M | $3.3B | ||
| Q2 25 | $639.8M | $3.4B | ||
| Q1 25 | $596.7M | $3.4B | ||
| Q4 24 | $568.5M | $3.5B | ||
| Q3 24 | $561.5M | $3.6B | ||
| Q2 24 | $548.2M | $3.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.23× | ||
| Q3 25 | — | 2.70× | ||
| Q2 25 | — | 2.63× | ||
| Q1 25 | — | 2.23× | ||
| Q4 24 | — | 2.13× | ||
| Q3 24 | — | 2.06× | ||
| Q2 24 | — | 1.73× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | — |
| Free Cash FlowOCF − Capex | $-18.7M | — |
| FCF MarginFCF / Revenue | -9.6% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $116.7M | ||
| Q3 25 | $1.0M | $47.5M | ||
| Q2 25 | $-32.4M | $34.4M | ||
| Q1 25 | $-43.4M | $6.3M | ||
| Q4 24 | $-26.2M | $181.1M | ||
| Q3 24 | $-18.6M | $52.2M | ||
| Q2 24 | $-30.1M | $48.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | — | ||
| Q2 25 | $-32.4M | — | ||
| Q1 25 | $-43.7M | — | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | — | ||
| Q2 24 | $-30.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -21.6% | — | ||
| Q1 25 | -36.0% | — | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | — | ||
| Q2 24 | -34.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
BDN
| Rents | $120.7M | 95% |
| Third party management fees, labor reimbursement and leasing | $4.7M | 4% |
